Photosensitivity in cutaneous lupus erythematosus

Photodermatology Photoimmunology and Photomedicine

Volumn 29, Issue 1, 2013, Pages 4-11

  Kim, Andrew ^a   Chong, Benjamin F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cutaneous lupus erythematosus; Photosensitivity; Phototesting; Ultraviolet radiation

Indexed keywords

VASCULAR CELL ADHESION MOLECULE 1;

CLINICAL PROTOCOL; DNA DAMAGE; HUMAN; MEDLINE; PHOTOSENSITIVITY; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SELF REPORT; SKIN LUPUS ERYTHEMATOSUS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; MICE; PHOTOSENSITIVITY DISORDERS; ULTRAVIOLET RAYS;

EID: 84871861256     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/phpp.12018     Document Type: Review

References (52)

1. Giliam JN, Sontheimer RD. Distinctive cutaneous subsets in the spectrum of lupus erythematosus. J Am Acad Dermatol 1981; 4: 471-475.
2. Durosaro O, Davis MD, Reed KB, Rohlinger AL. Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study. Arch Dermatol 2009; 145: 249-253.
3. Grönhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol 2011; 164: 1335-1341.
4. Klein R, Moghadam-Kia S, Taylor L etal. Quality of life in cutaneous lupus erythematosus. J Am Acad Dermatol 2011; 64: 849-858.
5. Vasquez R, Wang D, Tran QP etal. A multi-center, cross-sectional study on quality of life in cutaneous lupus erythematosus patients. Br J Dermatol 2012 [Epub ahead of print].
6. O'Quinn SE, Cole J, Many H. Problems of disability and rehabilitation in patients with chronic skin diseases. Arch Dermatol 1972; 105: 35-41.
7. Foering K, Goreshi R, Klein R etal. Prevalence of self-report photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol 2012; 66: 220-228.
8. Kuhn A, Herrmann M, Kleber S etal. Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation. Arthritis Rheum 2006; 54: 939-950.
9. Furukawa F, Itoh T, Wakita H etal. Keratinocytes from patients with lupus erythematosus show enhanced cytotoxicity to ultraviolet radiation and to antibody-mediated cytotoxicity. Clin Exp Immunol 1999; 118: 164-170.
10. Kuhn A, Sonntag M, Richter-Hintz D etal. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 2001; 45: 86-95.
11. Köck A, Schwarz T, Kirnbauer R etal. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J Exp Med 1990; 172: 1609-1614.
12. Casciola-Rosen L, Rosen A. Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus 1997; 6: 175-180.
13. Golan TD, Elkon KB, Gharavi AE, Krueger JG. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J Clin Invest 1992; 90: 1067-1076.
14. Mitchell D. Revisiting the photochemistry of solar UVA in human skin. Proc Natl Acad Sci U S A 2006; 103: 13567-13568.
15. Fuchs J, Huflejt ME, Rothfuss LM, Wilson DS, Carcamo G, Packer L. Acute effects of near ultraviolet and visible light on the cutaneous antioxidant defense system. Photochem Photobiol 1989; 50: 739-744.
16. Wlaschek M, Heinen G, Poswig A, Schwarz A, Krieg T, Scharffetter-Kochanek K. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 1994; 59: 550-556.
17. Halliday GM, Byrne SN, Damian DL. Ultraviolet A radiation: its role in immunosuppression and carcinogenesis. Semin Cutan Med Surg 2011; 30: 214-221.
18. Wolska H, Blłaszczyk M, Jablłońska S. Phototests in patients with various forms of lupus erythematosus. Int J Dermatol 1989; 28: 98-103.
19. Van Weelden H, Velthuis PJ, Baart De La Faille H. Light-induced skin lesions in lupus erythematosus: photobiological studies. Arch Dermatol Res 1989; 281: 470-474.
20. Hasan T, Nyberg F, Stephansson E etal. Photosensitivity in lupus erythematosus, UV photoprovocation results compared with history of photosensitivity and clinical findings. Br J Dermatol 1997; 136: 699-705.
21. Leenutaphong V, Boonchai W. Phototesting in oriental patients with lupus erythematosus. Photodermatol Photoimmunol Photomed 1999; 15: 7-12.
22. Kuhn A, Gensch K, Haust M etal. Photoprotective effects of a broad-spectrum sunscreen in ultraviolet-induced cutaneous lupus erythematosus: a randomized, vehicle-controlled, double-blind study. J Am Acad Dermatol 2011; 64: 37-48.
23. Zandman-Goddard G, Solomon M, Rosman Z, Peeva E, Shoenfeld Y. Environment and lupus-related diseases. Lupus 2012; 21: 241-250.
24. Tan EM, Cohen AS, Fries JF etal. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
25. Kuhn A, Ruland V, Bonsmann G. Photosensitivity, phototesting, and photoprotection in cutaneous lupus erythematosus. Lupus 2010; 19: 1036-1046.
26. Sanders CJ, Van Weelden H, Kazzaz GA, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. Photosensitivity in patients with lupus erythematosus: a clinical and photobiological study of 100 patients using a prolonged phototest protocol. Br J Dermatol 2003; 149: 131-137.
27. Lehmann P, Hölzle E, Von Kries R, Plewig G. Lichtdiagnostische Verfahren bei Patienten mit Verdacht auf Photodermatosen. Zentralbl Haut Und Geschlechtskr 1986; 152: 667-682.
28. Lehmann P, Hölzle E, Kind P, Goerz G, Plewig G. Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 1990; 22: 181-187.
29. Beutner EH, Blaszczyk M, Jablonska S, Chorzelski TP, Kumar V, Wolska H. Studies on criteria of the European Academy of Dermatology and Venerology for the classification of cutaneous lupus erythematosus. I. Selection of clinical groups and study factors. Int J Dermatol 1991; 30: 411-417.
30. Kuhn A, Wozniacka A, Szepietowski JC etal. Photoprovocation in cutaneous lupus erythematosus: a multicenter study evaluating a standardized protocol. J Invest Dermatol 2011; 131: 1622-1630.
31. Doria A, Biasinutto C, Ghirardello A etal. Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition. Lupus 1996; 5: 263-268.
32. Wozniacka A, Lesiak A, McCauliffe DP, Sysa-Jedrzejowska A. Photoprotective properties of chloroquine phosphate. J Eur Acad Dermatol Venereol 2007; 21: 1133-1134.
33. Cutillas-Marco E, Morales-Suárez-Varela M, Marquina-Vila A, Grant W. Serum 25-hydroxyvitamin D levels in patients with cutaneous lupus erythematosus in a Mediterranean region. Lupus 2010; 19: 810-814.
34. Word AP, Perese F, Tseng LC, Adams-Huet B, Olsen NJ, Chong BF. 25-Hydroxyvitamin D levels in African-American and Caucasian/Hispanic subjects with cutaneous lupus erythematosus. Br J Dermatol 2012; 166: 372-379.
35. Holick MF, Binkley NC, Bischoff-Ferrari HA etal. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930.
36. Ross AC, Manson JE, Abrams SA etal. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53-58.
37. McGrath H, Martinez-Osuna P, Lee FA. Ultraviolet-A1 (340-400nm) irradiation therapy in systemic lupus erythematosus. Lupus 1996; 5: 269-274.
38. Menon Y, McCarthy K, McGrath H Jr. Reversal of brain dysfunction with UV-A1 irradiation in a patient with systemic lupus. Lupus 2003; 12: 479-482.
39. Szegedi A, Simics E, Aleksza M etal. Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology 2005; 44: 925-931.
40. Polderman MC, Huizinga TW, Le Cessie S, Pavel S. UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 2001; 60: 112-115.
41. Polderman MC, Le Cessie S, Huizinga TW, Pavel S. Efficacy of UVA-1 cold light as an adjuvant therapy for systemic lupus erythematosus. Rheumatology 2004; 43: 1402-1404.
42. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999; 112: 3-12.
43. Smit N, Musson R, Romijn F, Van Rossum H, Van Pelt J. Effects of ultraviolet A-1 radiation on calcineurin activity and cytokine production in (skin) cell cultures. Photochem Photobiol 2010; 86: 360-366.
44. McGrath H Jr, Bak E, Michalski JP. Ultraviolet-A light prolongs survival and improves immune function in (New Zealand black x New Zealand white) F1 hybrid mice. Arthritis Rheum 1987; 30: 557-561.
45. Mikita N, Kanazawa N, Yoshimasu T etal. The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL/lpr mice. Clin Dev Immunol 2009; 2009: 673952.
46. Sönnichsen N, Meffert H, Kunzelmann V, Audring H. UVA-1 therapy of subacute cutaneous lupus erythematosus. Hautarzt 1993; 44: 723-725.
47. McGrath H, Jr, Bell JR, Haynes MR, Martinez-Osuna P. Ultraviolet-A irradiation therapy for patients with systemic lupus erythematosus: a pilot study. Curr Ther Res 1994; 55: 373-381.
48. McGrath H, Jr. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1994; 12: 129-135.
49. McGrath H Jr. Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient. Lupus 2005; 14: 859-861.
50. Jabara B, Dahlgren M, McGrath H Jr. Interstitial lung disease and pulmonary hypertension responsive to low-dose ultraviolet A1 irradiation in lupus. J Clin Rheumatol 2010; 16: 188-189.
51. Pavel S. Light therapy (with UVA-1) for SLE patients: is it a good or bad idea? Rheumatology 2006; 45: 653-655.
52. Polderman MC, Van Kooten C, Smit NP, Kamerling SW, Pavel S. Ultraviolet-A (UVA-1) radiation suppresses immunoglobulin production of activated B lymphocytes in vitro. Clin Exp Immunol 2006; 145: 528-534.